An RNA-Seq-Based Framework for Characterizing Canine Prostate Cancer and Prioritizing Clinically Relevant Biomarker Candidate Genes

Prostate cancer (PCa) in dogs is a highly malignant disease akin to its human counterpart. In contrast to the situation in humans, multi-gene approaches facilitating risk stratification of canine PCa are barely established. The aims of this study were the characterization of the transcriptional land...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Heike Thiemeyer, Leila Taher, Jan Torben Schille, Eva-Maria Packeiser, Lisa K. Harder, Marion Hewicker-Trautwein, Bertram Brenig, Ekkehard Schütz, Julia Beck, Ingo Nolte, Hugo Murua Escobar
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/1d53b455aeab4aa2a873fbb0640d6ac9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1d53b455aeab4aa2a873fbb0640d6ac9
record_format dspace
spelling oai:doaj.org-article:1d53b455aeab4aa2a873fbb0640d6ac92021-11-11T16:58:07ZAn RNA-Seq-Based Framework for Characterizing Canine Prostate Cancer and Prioritizing Clinically Relevant Biomarker Candidate Genes10.3390/ijms2221114811422-00671661-6596https://doaj.org/article/1d53b455aeab4aa2a873fbb0640d6ac92021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11481https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Prostate cancer (PCa) in dogs is a highly malignant disease akin to its human counterpart. In contrast to the situation in humans, multi-gene approaches facilitating risk stratification of canine PCa are barely established. The aims of this study were the characterization of the transcriptional landscape of canine PCa and the identification of diagnostic, prognostic and/or therapeutic biomarkers through a multi-step screening approach. RNA-Sequencing of ten malignant tissues and fine-needle aspirations (FNA), and 14 nonmalignant tissues and FNAs was performed to find differentially expressed genes (DEGs) and deregulated pathways. The 4098 observed DEGs were involved in 49 pathways. These 49 pathways could be grouped into five superpathways summarizing the hallmarks of canine PCa: (i) inflammatory response and cytokines; (ii) regulation of the immune system and cell death; (iii) cell surface and PI3K signaling; (iv) cell cycle; and (v) phagosome and autophagy. Among the highly deregulated, moderately to strongly expressed DEGs that were members of one or more superpathways, 169 DEGs were listed in relevant databases and/or the literature and included members of the PCa pathway, oncogenes, prostate-specific genes, and druggable genes. These genes are novel and promising candidate diagnostic, prognostic and/or therapeutic canine PCa biomarkers.Heike ThiemeyerLeila TaherJan Torben SchilleEva-Maria PackeiserLisa K. HarderMarion Hewicker-TrautweinBertram BrenigEkkehard SchützJulia BeckIngo NolteHugo Murua EscobarMDPI AGarticlecanine prostate cancerRNA-Sequencingwhole transcriptome analysiscandidate biomarker genesanimal modelmolecular diagnosticsBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11481, p 11481 (2021)
institution DOAJ
collection DOAJ
language EN
topic canine prostate cancer
RNA-Sequencing
whole transcriptome analysis
candidate biomarker genes
animal model
molecular diagnostics
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle canine prostate cancer
RNA-Sequencing
whole transcriptome analysis
candidate biomarker genes
animal model
molecular diagnostics
Biology (General)
QH301-705.5
Chemistry
QD1-999
Heike Thiemeyer
Leila Taher
Jan Torben Schille
Eva-Maria Packeiser
Lisa K. Harder
Marion Hewicker-Trautwein
Bertram Brenig
Ekkehard Schütz
Julia Beck
Ingo Nolte
Hugo Murua Escobar
An RNA-Seq-Based Framework for Characterizing Canine Prostate Cancer and Prioritizing Clinically Relevant Biomarker Candidate Genes
description Prostate cancer (PCa) in dogs is a highly malignant disease akin to its human counterpart. In contrast to the situation in humans, multi-gene approaches facilitating risk stratification of canine PCa are barely established. The aims of this study were the characterization of the transcriptional landscape of canine PCa and the identification of diagnostic, prognostic and/or therapeutic biomarkers through a multi-step screening approach. RNA-Sequencing of ten malignant tissues and fine-needle aspirations (FNA), and 14 nonmalignant tissues and FNAs was performed to find differentially expressed genes (DEGs) and deregulated pathways. The 4098 observed DEGs were involved in 49 pathways. These 49 pathways could be grouped into five superpathways summarizing the hallmarks of canine PCa: (i) inflammatory response and cytokines; (ii) regulation of the immune system and cell death; (iii) cell surface and PI3K signaling; (iv) cell cycle; and (v) phagosome and autophagy. Among the highly deregulated, moderately to strongly expressed DEGs that were members of one or more superpathways, 169 DEGs were listed in relevant databases and/or the literature and included members of the PCa pathway, oncogenes, prostate-specific genes, and druggable genes. These genes are novel and promising candidate diagnostic, prognostic and/or therapeutic canine PCa biomarkers.
format article
author Heike Thiemeyer
Leila Taher
Jan Torben Schille
Eva-Maria Packeiser
Lisa K. Harder
Marion Hewicker-Trautwein
Bertram Brenig
Ekkehard Schütz
Julia Beck
Ingo Nolte
Hugo Murua Escobar
author_facet Heike Thiemeyer
Leila Taher
Jan Torben Schille
Eva-Maria Packeiser
Lisa K. Harder
Marion Hewicker-Trautwein
Bertram Brenig
Ekkehard Schütz
Julia Beck
Ingo Nolte
Hugo Murua Escobar
author_sort Heike Thiemeyer
title An RNA-Seq-Based Framework for Characterizing Canine Prostate Cancer and Prioritizing Clinically Relevant Biomarker Candidate Genes
title_short An RNA-Seq-Based Framework for Characterizing Canine Prostate Cancer and Prioritizing Clinically Relevant Biomarker Candidate Genes
title_full An RNA-Seq-Based Framework for Characterizing Canine Prostate Cancer and Prioritizing Clinically Relevant Biomarker Candidate Genes
title_fullStr An RNA-Seq-Based Framework for Characterizing Canine Prostate Cancer and Prioritizing Clinically Relevant Biomarker Candidate Genes
title_full_unstemmed An RNA-Seq-Based Framework for Characterizing Canine Prostate Cancer and Prioritizing Clinically Relevant Biomarker Candidate Genes
title_sort rna-seq-based framework for characterizing canine prostate cancer and prioritizing clinically relevant biomarker candidate genes
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/1d53b455aeab4aa2a873fbb0640d6ac9
work_keys_str_mv AT heikethiemeyer anrnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes
AT leilataher anrnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes
AT jantorbenschille anrnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes
AT evamariapackeiser anrnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes
AT lisakharder anrnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes
AT marionhewickertrautwein anrnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes
AT bertrambrenig anrnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes
AT ekkehardschutz anrnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes
AT juliabeck anrnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes
AT ingonolte anrnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes
AT hugomuruaescobar anrnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes
AT heikethiemeyer rnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes
AT leilataher rnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes
AT jantorbenschille rnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes
AT evamariapackeiser rnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes
AT lisakharder rnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes
AT marionhewickertrautwein rnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes
AT bertrambrenig rnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes
AT ekkehardschutz rnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes
AT juliabeck rnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes
AT ingonolte rnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes
AT hugomuruaescobar rnaseqbasedframeworkforcharacterizingcanineprostatecancerandprioritizingclinicallyrelevantbiomarkercandidategenes
_version_ 1718432163219636224